Page last updated: 2024-09-05

phosphatidylcholines and cilomilast

phosphatidylcholines has been researched along with cilomilast in 1 studies

Compound Research Comparison

Studies (phosphatidylcholines)	Trials (phosphatidylcholines)	Recent Studies (post-2010) (phosphatidylcholines)	Studies (cilomilast)	Trials (cilomilast)	Recent Studies (post-2010) (cilomilast)
32,204	443	5,593	162	13	42

Protein Interaction Comparison

Protein	Taxonomy	cilomilast (IC50)
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens (human)	0.018
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.018
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	0.018
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	0.018
cGMP-dependent 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	2.3453
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	Homo sapiens (human)	2.3453
cGMP-specific 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	2.3453
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Rattus norvegicus (Norway rat)	0.113
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Rattus norvegicus (Norway rat)	0.113
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Rattus norvegicus (Norway rat)	0.1623
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens (human)	0.3113
Sodium-dependent serotonin transporter	Rattus norvegicus (Norway rat)	0.062
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Rattus norvegicus (Norway rat)	0.113
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	Homo sapiens (human)	2.3453
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens (human)	0.4623
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Homo sapiens (human)	0.818
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens (human)	0.4642
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens (human)	4.259
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens (human)	10
Beta-2 adrenergic receptor	Cavia porcellus (domestic guinea pig)	0.12
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	Homo sapiens (human)	2.3453
cAMP-specific 3',5'-cyclic phosphodiesterase 7B	Homo sapiens (human)	2.3453
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	Homo sapiens (human)	2.3453

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elzoghby, AO; Fang, JY; Hwang, TL; Lin, CY; Liu, FC; Yu, HP	1

Other Studies

1 other study(ies) available for phosphatidylcholines and cilomilast

Article	Year
Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge. Journal of nanobiotechnology, 2018, Mar-30, Volume: 16, Issue:1 Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Biomarkers; Calcium; Cyclohexanecarboxylic Acids; Humans; Lipopolysaccharides; Liposomes; Lung; Male; Mice, Inbred C57BL; Nanoparticles; Neutrophil Activation; Neutrophils; Nitriles; Particle Size; Phosphatidylcholines; Static Electricity; Tissue Distribution	2018

Article

Year

Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge.

Journal of nanobiotechnology, 2018, Mar-30, Volume: 16, Issue:1

Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Biomarkers; Calcium; Cyclohexanecarboxylic Acids; Humans; Lipopolysaccharides; Liposomes; Lung; Male; Mice, Inbred C57BL; Nanoparticles; Neutrophil Activation; Neutrophils; Nitriles; Particle Size; Phosphatidylcholines; Static Electricity; Tissue Distribution

2018